Position in CRBU
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$17,600
New position
Shares Held
10,000
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 137 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $6,120,036 across 7 Biotechnology names. CRBU ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
94,250 | $4,341,155 | |
| 2 | ARDX |
Ardelyx, Inc.
|
226,400 | $1,154,640 | |
| 3 | CRMD |
CorMedix Inc.
|
54,000 | $423,900 | |
| 4 | GALT |
Galectin Therapeutics Inc
|
30,000 | $139,200 | |
| 5 | DYAI |
Dyadic International Inc
|
41,745 | $37,570 | |
| 6 | CRBU |
Caribou Biosciences, Inc.
This page
|
10,000 | $17,600 | |
| 7 | HRTX |
Heron Therapeutics, Inc. /De/
|
13,992 | $5,971 |
All Filings in CRBU
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,600 | 10,000 | Shares | Sole | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||